Pharmacokinetics and metabolism of hexachlorobenzene in the rat and the rhesus monkey. 1978

R S Yang, and K A Pittman, and D R Rourke, and V B Stein

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008297 Male Males
D002722 Chlorobenzenes Aromatic organic compounds with the chemical formula C6H5Cln.
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006444 Hemoglobin C A commonly occurring abnormal hemoglobin in which lysine replaces a glutamic acid residue at the sixth position of the beta chains. It results in reduced plasticity of erythrocytes.
D006581 Hexachlorobenzene An agricultural fungicide and seed treatment agent. HCB
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000882 Haplorhini A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes). Anthropoidea,Monkeys,Anthropoids,Monkey
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

R S Yang, and K A Pittman, and D R Rourke, and V B Stein
May 1979, Bulletin of environmental contamination and toxicology,
R S Yang, and K A Pittman, and D R Rourke, and V B Stein
January 1979, Arzneimittel-Forschung,
R S Yang, and K A Pittman, and D R Rourke, and V B Stein
November 1993, Investigational new drugs,
R S Yang, and K A Pittman, and D R Rourke, and V B Stein
January 1981, European journal of drug metabolism and pharmacokinetics,
R S Yang, and K A Pittman, and D R Rourke, and V B Stein
October 1977, Toxicology and applied pharmacology,
R S Yang, and K A Pittman, and D R Rourke, and V B Stein
January 1982, Drug metabolism and disposition: the biological fate of chemicals,
R S Yang, and K A Pittman, and D R Rourke, and V B Stein
January 1988, European journal of drug metabolism and pharmacokinetics,
R S Yang, and K A Pittman, and D R Rourke, and V B Stein
January 1974, Journal of pharmaceutical sciences,
R S Yang, and K A Pittman, and D R Rourke, and V B Stein
October 1991, Cancer research,
R S Yang, and K A Pittman, and D R Rourke, and V B Stein
May 1980, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!